DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 69.70.
| Share Price | ₹6,741.2 | Jun 19,2026 |
| Market Cap | ₹178,977.5 Cr | |
| Earnings-TTM | ₹2,568.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 69.70x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹178,977.5 Cr] as on Jun 19,2026
(/) Earnings [ ₹2,568.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 69.70x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 69.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.17x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 48.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 69.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 39.49x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| DIVIS LABORATORIES | 2,568.00 | 69.70 | 178,977.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.12 | 440,794.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 70.07 | 149,820.0 |
| CIPLA LTD | 3,869.79 | 28.26 | 109,370.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.61 | 106,133.0 |
| MANKIND PHARMA LTD | 1,926.41 | 51.82 | 99,835.6 |
| LUPIN LTD | 5,355.47 | 20.08 | 107,537.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.44 | 107,758.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 24.61 | 86,183.0 |
| LAURUS LABS LTD | 889.85 | 85.77 | 76,323.8 |
| BIOCON LTD | 368.80 | 182.70 | 67,381.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.08x |
| Max industry PE | 182.70x |
| Median industry PE | 38.12x |
| Average industry PE | 56.20x |
You may also like the below Video Courses